STOCK TITAN

Talkspace Announces Second Quarter 2024 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Talkspace (NASDAQ: TALK) reported strong Q2 2024 results, with total revenue growing 29% year-over-year to $46.1 million. This growth was primarily driven by a 62% increase in Payor revenue and a 20% rise in Direct to Enterprise revenue. The company's net loss significantly improved to $0.5 million from $4.7 million in the previous year. Adjusted EBITDA turned positive at $1.2 million, compared to a loss of $4.0 million in Q2 2023.

Key highlights include:

  • Expanded covered lives to over 145 million
  • Launched Medicare offering in 12 states
  • Approved additional $25 million share repurchase program
  • Maintained fiscal year 2024 revenue guidance of $185-$195 million
  • Adjusted EBITDA guidance of $4-$8 million for FY 2024

Talkspace (NASDAQ: TALK) ha riportato risultati solidi per il secondo trimestre del 2024, con un fatturato totale che è cresciuto del 29% rispetto all'anno precedente, raggiungendo i 46,1 milioni di dollari. Questa crescita è stata principalmente guidata da un aumento del 62% delle entrate da Payor e da un incremento del 20% delle entrate Dirette per le Imprese. La perdita netta dell'azienda è migliorata significativamente, passando da 4,7 milioni di dollari dell'anno scorso a 0,5 milioni di dollari. L'EBITDA rettificato è diventato positivo, raggiungendo 1,2 milioni di dollari, rispetto a una perdita di 4 milioni di dollari nel secondo trimestre del 2023.

I principali punti salienti includono:

  • Espansione della copertura a oltre 145 milioni di vite
  • Avvio dell'offerta Medicare in 12 stati
  • Approvato un programma aggiuntivo di riacquisto di azioni da 25 milioni di dollari
  • Mantenuta la previsione di fatturato per l'anno fiscale 2024 tra 185 e 195 milioni di dollari
  • Previsione di EBITDA rettificato tra 4 e 8 milioni di dollari per l'anno fiscale 2024

Talkspace (NASDAQ: TALK) reportó resultados sólidos para el segundo trimestre de 2024, con ingresos totales que crecieron un 29% interanual, alcanzando los 46,1 millones de dólares. Este crecimiento fue impulsado principalmente por un aumento del 62% en los ingresos de Payor y un incremento del 20% en los ingresos directos a empresas. La pérdida neta de la compañía mejoró significativamente, disminuyendo de 4,7 millones de dólares del año anterior a 0,5 millones de dólares. El EBITDA ajustado se volvió positivo con 1,2 millones de dólares, en comparación con una pérdida de 4 millones de dólares en el segundo trimestre de 2023.

Los aspectos destacados incluyen:

  • Expansión de la cobertura a más de 145 millones de vidas
  • Lanzamiento de la oferta de Medicare en 12 estados
  • Autorizado un programa adicional de recompra de acciones de 25 millones de dólares
  • Manteniendo la guía de ingresos para el año fiscal 2024 entre 185 y 195 millones de dólares
  • Guía de EBITDA ajustado de entre 4 y 8 millones de dólares para el año fiscal 2024

Talkspace (NASDAQ: TALK)는 2024년 2분기 강력한 실적을 발표했습니다. 총 수익이 전년 대비 29% 증가하여 4,610만 달러에 달했습니다. 이 성장은 주로 Payor 수익이 62% 증가하고 엔터프라이즈 직접 수익이 20% 증가한 데 힘입은 것입니다. 회사의 순손실은 작년의 470만 달러에서 50만 달러로 크게 개선되었습니다. 조정 EBITDA는 120만 달러로 긍정적으로 전환되었으며, 이는 2023년 2분기에서 400만 달러의 손실과 비교됩니다.

주요 하이라이트는 다음과 같습니다:

  • 보장된 생명이 1억 4,500만 이상으로 확대됨
  • 12개 주에서 Medicare 제공 시작
  • 2,500만 달러의 추가 자사주 매입 프로그램 승인
  • 2024 회계 연도 수익 가이던스 1억 8,500만 - 1억 9,500만 달러 유지
  • 2024 회계 연도 조정 EBITDA 가이던스 400만 - 800만 달러

Talkspace (NASDAQ: TALK) a rapporté de solides résultats pour le deuxième trimestre de 2024, avec un chiffre d'affaires total en hausse de 29 % par rapport à l'année précédente, atteignant 46,1 millions de dollars. Cette croissance a été principalement soutenue par une augmentation de 62 % des revenus Payor et une hausse de 20 % des revenus directs aux entreprises. La perte nette de l'entreprise s'est considérablement améliorée, passant de 4,7 millions de dollars l'année précédente à 0,5 million de dollars. L'EBITDA ajusté est devenu positif avec 1,2 million de dollars, contre une perte de 4 millions de dollars au deuxième trimestre de 2023.

Les points saillants incluent :

  • Extension de la couverture à plus de 145 millions de vies
  • Lancement de l'offre Medicare dans 12 états
  • Approbation d'un programme de rachat d'actions supplémentaire de 25 millions de dollars
  • Maintien des prévisions de revenus pour l'exercice 2024 entre 185 et 195 millions de dollars
  • Prévisions d'EBITDA ajusté de 4 à 8 millions de dollars pour l'exercice 2024

Talkspace (NASDAQ: TALK) hat im zweiten Quartal 2024 starke Ergebnisse berichtet, wobei der Gesamtumsatz im Vergleich zum Vorjahr um 29% auf 46,1 Millionen Dollar gewachsen ist. Dieses Wachstum wurde hauptsächlich durch einen Anstieg der Payor-Einnahmen um 62% und einen Anstieg der direkten Unternehmenseinnahmen um 20% getrieben. Der Nettoverlust des Unternehmens hat sich signifikant von 4,7 Millionen Dollar im Vorjahr auf 0,5 Millionen Dollar verbessert. Das bereinigte EBITDA wurde positiv und belief sich auf 1,2 Millionen Dollar, verglichen mit einem Verlust von 4 Millionen Dollar im zweiten Quartal 2023.

Wichtige Highlights sind:

  • Erweiterte Versicherte auf über 145 Millionen Menschen
  • Medicare-Angebot in 12 Bundesstaaten gestartet
  • Zusätzliches Aktienrückkaufprogramm über 25 Millionen Dollar genehmigt
  • Fiskalische Umsatzprognose für das Jahr 2024 von 185 bis 195 Millionen Dollar beibehalten
  • Bereinigte EBITDA-Prognose von 4 bis 8 Millionen Dollar für das Geschäftsjahr 2024
Positive
  • Total revenue grew 29% year-over-year to $46.1 million
  • Payor revenue increased 62% year-over-year
  • Direct to Enterprise revenue rose 20% year-over-year
  • Net loss improved to $0.5 million from $4.7 million in Q2 2023
  • Adjusted EBITDA turned positive at $1.2 million
  • Expanded covered lives to over 145 million
  • Launched Medicare offering in 12 states
  • Approved additional $25 million share repurchase program
Negative
  • Consumer revenue declined 28% year-over-year
  • Gross margin declined to 45.5% from 50% in the prior-year period
  • Operating expenses increased 1% year-over-year

Insights

Talkspace's Q2 2024 results show significant progress towards profitability. Total revenue grew 29% year-over-year to $46.1 million, driven by a 62% increase in Payor revenue. The company reduced its GAAP Net loss to $0.5 million from $4.7 million year-over-year and achieved Adjusted EBITDA of $1.2 million, marking its second consecutive quarter of profitability on this metric.

The shift in revenue mix towards Payor led to a slight decline in gross margin to 45.5% from 50% last year. However, the company's focus on operational efficiency is evident, with operating expenses increasing only 1% year-over-year. The additional $25 million share repurchase program signals management's confidence in the company's financial position and future prospects.

Talkspace's Q2 results reflect strong market penetration and strategic positioning. The company expanded its covered lives to over 145 million, a 33% increase year-over-year. This expansion, coupled with the launch of Medicare offerings in 12 states, indicates significant growth potential in the telehealth mental health sector.

However, the 22% decline in Consumer active members suggests challenges in the direct-to-consumer segment. The 20% growth in Direct to Enterprise revenue highlights the company's successful pivot towards B2B channels. Talkspace's maintained guidance for FY2024 revenue of $185-195 million demonstrates confidence in sustained growth, positioning the company as a key player in the evolving mental health care landscape.

Talkspace's Q2 performance underscores the growing demand for accessible mental health services. The 49% increase in completed Payor sessions indicates strong adoption of telehealth mental health services among insurance-covered patients. The company's focus on enhancing provider experience and patient journey is important in a competitive telehealth landscape.

The launch of Medicare offerings in 12 states is a strategic move to tap into the growing senior mental health market. However, the decline in Consumer active members suggests potential saturation or increased competition in the direct-to-consumer segment. Talkspace's ability to optimize marketing efforts and differentiate its product quality will be key to maintaining its growth trajectory in both B2B and B2C segments.

2Q 2024 Total revenue grew 29% year-over-year, driven by 62%
year-over-year growth in Payor revenue

Reduced GAAP Net loss to $0.5 million from $4.7 million year-over-year

2Q 2024 Adjusted EBITDA1 of $1.2 million

Board approved an additional $25 million share repurchase program

NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Talkspace, Inc. (“Talkspace” or the “Company”) (NASDAQ: TALK), today reported second quarter 2024 financial results.

  Three Months Six Months
   
June 30, 2024 (Unaudited) Results % Variance from Prior Year Results % Variance from Prior Year
(In thousands unless otherwise noted)        
Number of eligible lives at period end (in millions)  145.3  33%  145.3  33%
Number of completed Payor sessions  298.6  49%  582.8  57%
Number of Consumer active members at period end  10.7  (22)%  10.7  (22)%
         
Total revenue $46,058  29% $91,474  33%
Gross profit $20,951  18% $42,682  24%
Gross margin %  45.5%     46.7%   
Operating expenses $24,437  1% $47,847  (4)%
Net loss $(474) 90% $(1,940) 86%
Adjusted EBITDA1 $1,179  130% $1,953  119%
Cash and cash equivalents at period end $114,913    $114,913   
               
(1) Adjusted EBITDA is a non-GAAP financial measure. For a definition of the measure and a reconciliation to the most direct comparable GAAP measure, see “Reconciliation of Non-GAAP Results to GAAP Results.”
 

“Our robust second quarter performance reflects continued business execution, resulting in 29% revenue growth and our second consecutive quarter of Adjusted EBITDA profitability. We expanded our covered lives to over 145 million, launched our Medicare offering in 12 states, and made strides in optimizing our marketing efforts,” said Dr. Jon Cohen, CEO of Talkspace.

Dr. Cohen added, “This positive momentum stems from our ongoing commitment to enhancing both provider experience and patient journey, while focusing on product quality - key differentiators for Talkspace. I’m encouraged by our results, which underscore our dedication to making high-quality mental health care more accessible.”

Second Quarter 2024 Key Performance Metrics

  • Revenue increased 29% over the prior-year period to $46.1 million, driven by a 62% year-over-year increase in Payor revenue and a 20% year-over-year increase in Direct to Enterprise (“DTE”) revenue; partially offset by a 28% year-over-year Consumer revenue decline.
  • Gross profit increased 18% over the prior-year period to $21 million, and gross margin declined to 45.5% from 50% in the prior-year period, driven by a shift in revenue mix towards Payor.
  • Operating expenses were $24.4 million, an increase of 1% year-over-year, driven primarily by higher general and administrative expenses.
  • Net loss was $(0.5) million, an improvement from $(4.7) million net loss in the second quarter of 2023, primarily driven by an increase in revenues, partially offset by an increase in cost of revenues.
  • Adjusted EBITDA was $1.2 million, an improvement from $(4.0) million in the second quarter of 2023, primarily driven by an increase in revenues, partially offset by an increase in cost of revenues.

Financial Guidance

Talkspace continues to expect fiscal year 2024 revenue to be in the range of $185 million to $195 million, growth of 23-30%, and adjusted EBITDA to be in the range of $4 million to $8 million.

Share Repurchase Program

During the second quarter of 2024, Talkspace repurchased $8.0 million of common stock under its initial share repurchase program. On August 1, 2024 the Company’s Board of Directors approved an additional share repurchase program authorizing the Company to repurchase up to twenty-five million dollars ($25 million) over the next 24 months. With the new authorization, the Company may repurchase, in aggregate, up to thirty-two million dollars ($32 million) of its outstanding shares of common stock during the remainder of the programs. The Company may repurchase the shares periodically through various methods in compliance with applicable state and federal securities laws. The timing of purchases and the target number of shares will be determined by Management at its discretion based on an evaluation of the Company’s stock price, market conditions and other corporate considerations. Such repurchases will be funded from cash on hand. The repurchase program may be modified, suspended, or discontinued at any time at the Company’s discretion without prior notice.

Conference Call, Presentation Slides, and Webcast Details

The Second Quarter 2024 earnings conference call and webcast will be held Tuesday, August 6, 2024, at 8:30 a.m. E.T. The conference call will be available via audio webcast at investors.talkspace.com and can also be accessed by dialing (888) 330-2391 for U.S. participants, or +1 (240) 789-2702 for international participants, and referencing participant code 2348878. A replay will be available shortly after the call’s completion and remain available for approximately 90 days.

About Talkspace

Talkspace (NASDAQ: TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall health and should be available to everyone.

Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). With Talkspace’s core therapy offerings, members are matched with one of thousands of licensed therapists within days and can engage in live video, audio, or chat sessions, and/or unlimited asynchronous text messaging sessions.

All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. More than 151 million Americans have access to Talkspace through their health insurance plans, employee assistance programs, our partnerships with leading healthcare companies, or as a free benefit through their employer, school, or government agency.

For more information, visit www.talkspace.com.

For Investors:
ICR Westwicke
TalkspaceIR@westwicke.com

For Media:
John Kim
SKDK
(310) 997-5963
jkim@skdknick.com

Forward Looking Statements

This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast”, “future”, “intend,” “may,” “might”, “opportunity”, “plan,” “possible”, “potential,” “predict,” “project,” “should,” “strategy”, “strive”, “target,” “will,” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to factors and the other risks and uncertainties described under the caption “Risk Factors” in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 13, 2024, subsequent quarterly reports on Form 10-Q and our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise unless required to do so under applicable law. We do not give any assurance that we will achieve our expectations.

Talkspace, Inc.
Condensed Consolidated Statements of Operations
 
  Three Months Ended
June 30,
     Six Months Ended
June 30,
    
  2024  2023  % Change  2024  2023  % Change 
(in thousands, except percentages, share and  per share data) Unaudited  Unaudited     Unaudited  Unaudited    
Revenue:                  
Payor revenue $29,945  $18,539   61.5  $58,453  $33,350   75.3 
DTE revenue  9,628   8,039   19.8   19,541   16,715   16.9 
Consumer revenue  6,485   9,067   (28.5)  13,480   18,916   (28.7)
Total revenue  46,058   35,645   29.2   91,474   68,981   32.6 
Cost of revenues  25,107   17,833   40.8   48,792   34,421   41.8 
Gross profit  20,951   17,812   17.6   42,682   34,560   23.5 
Operating expenses:                  
Research and development  2,163   4,171   (48.1)  5,902   9,524   (38.0)
Clinical operations, net  1,661   1,675   (0.8)  3,125   3,276   (4.6)
Sales and marketing  13,269   13,045   1.7   26,278   26,514   (0.9)
General and administrative  7,344   5,329   37.8   12,542   10,693   17.3 
Total operating expenses  24,437   24,220   0.9   47,847   50,007   (4.3)
Operating loss  (3,486)  (6,408)  45.6   (5,165)  (15,447)  66.6 
Financial (income), net  (3,044)  (1,712)  77.8   (3,422)  (2,136)  60.2 
Loss before taxes on income  (442)  (4,696)  90.6   (1,743)  (13,311)  86.9 
Taxes on income  32   8   300.0   197   151   30.5 
Net loss $(474) $(4,704)  89.9  $(1,940) $(13,462)  85.6 
Net loss per share:                  
Basic and Diluted $(0.00) $(0.03)  90.0  $(0.01) $(0.08)  87.5 
Weighted average number of common shares:                  
Basic and Diluted  169,148,522   164,195,697      168,997,734   163,003,363    


Talkspace, Inc.
Condensed Consolidated Balance Sheets
         
  June 30,
2024
  December 31,
2023
 
(in thousands) Unaudited    
ASSETS      
CURRENT ASSETS:      
Cash and cash equivalents $114,913  $123,908 
Accounts receivable, net  11,554   10,174 
Other current assets  2,302   5,718 
Total current assets  128,769   139,800 
Other long-term assets  5,021   2,421 
Total assets $133,790  $142,221 
LIABILITIES AND STOCKHOLDERS’ EQUITY      
CURRENT LIABILITIES:      
Accounts payable $7,733  $6,111 
Deferred revenues  2,733   3,069 
Accrued expenses and other current liabilities  7,313   12,468 
Total current liabilities  17,779   21,648 
Warrant liabilities  1,332   1,842 
Other liabilities  635   85 
Total liabilities  19,746   23,575 
STOCKHOLDERS’ EQUITY:      
Common stock  16   16 
Additional paid-in capital  386,352   389,014 
Accumulated deficit  (272,324)  (270,384)
Total stockholders’ equity  114,044   118,646 
Total liabilities and stockholders’ equity $133,790  $142,221 


Talkspace, Inc.
Condensed Consolidated Statements of Cash Flows
 
  Six Months Ended
June 30,
 
  2024  2023 
(in thousands) Unaudited  Unaudited 
Cash flows from operating activities:      
Net loss $(1,940) $(13,462)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization  421   608 
Stock-based compensation  5,359   4,432 
Remeasurement of warrant liabilities  (510)  (119)
(Increase) decrease in accounts receivable  (1,380)  1,220 
Decrease in other current assets  3,416   1,452 
Increase (decrease) in accounts payable  1,622   (977)
Decrease in deferred revenues  (336)  (672)
Decrease in accrued expenses and other current liabilities  (5,155)  (6,058)
Other  (79)  (172)
Net cash provided by (used in) operating activities  1,418   (13,748)
Cash flows from investing activities:      
Capitalized internal-use software costs  (2,110)   
Purchase of computer and equipment  (40)  (10)
Other     28 
Net cash (used in) provided by investing activities  (2,150)  18 
Cash flows from financing activities:      
Proceeds from exercise of stock options  1,584   1,490 
Payments for employee taxes withheld related to vested stock-based awards  (1,843)  (201)
Repurchase and cancellation of common stock  (8,004)   
Net cash (used in) provided by financing activities  (8,263)  1,289 
Net decrease in cash and cash equivalents  (8,995)  (12,441)
Cash and cash equivalents at the beginning of the period  123,908   138,545 
Cash and cash equivalents at the end of the period $114,913  $126,104 


Non-GAAP Financial Measures

In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to loss before income taxes, net loss, loss per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net loss and other GAAP results.

A reconciliation is provided below for adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation of adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful.

Adjusted EBITDA

We calculate adjusted EBITDA as net loss adjusted to exclude (i) depreciation and amortization, (ii) interest and other expenses (income), net, (iii) tax benefit and expense, (iv) stock-based compensation expense, and (v) certain non-recurring expenses, where applicable.

Talkspace, Inc.
Reconciliation of Non-GAAP Results to GAAP Results
 
  Three Months Ended
June 30,
  Six Months Ended
June 30,
 
  2024  2023  2024  2023 
(in thousands) Unaudited  Unaudited  Unaudited  Unaudited 
Net loss $(474) $(4,704) $(1,940) $(13,462)
Add:            
Depreciation and amortization  220   302   421   608 
Financial (income), net (1)  (3,044)  (1,712)  (3,422)  (2,136)
Taxes on income  32   8   197   151 
Stock-based compensation  3,107   2,129   5,359   4,432 
Non-recurring expenses (2)  1,338      1,338    
Adjusted EBITDA $1,179  $(3,977) $1,953  $(10,407)
 
(1) For the three months ended June 30, 2024 and 2023, financial (income), net, primarily consisted of $1.5 million (for both periods) of interest income from our money market accounts, and $1.7 million and $0.3 million, respectively, in unrealized gains resulting from the remeasurement of warrant liabilities. For the six months ended June 30, 2024 and 2023, financial (income), net, primarily consisted of $3.1 million and $2.1 million, respectively, of interest income from our money market accounts and $0.5 million and $0.1 million, respectively, in unrealized gains resulting from the remeasurement of warrant liabilities.

(2) For the three and six months ended June 30, 2024, non-recurring expenses, primarily consisted of severance costs related to the departure of key executives of Talkspace and other related costs.
 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/74a7505e-f12a-4d68-a3ff-716ecd785f0f


FAQ

What was Talkspace's revenue growth in Q2 2024?

Talkspace's total revenue grew 29% year-over-year to $46.1 million in Q2 2024.

How did Talkspace's net loss change in Q2 2024 compared to the previous year?

Talkspace's net loss improved to $0.5 million in Q2 2024, down from $4.7 million in Q2 2023.

What is Talkspace's revenue guidance for fiscal year 2024?

Talkspace maintains its fiscal year 2024 revenue guidance in the range of $185 million to $195 million, representing growth of 23-30%.

How many covered lives does Talkspace have as of Q2 2024?

Talkspace expanded its covered lives to over 145 million as of Q2 2024.

What new share repurchase program did Talkspace announce in Q2 2024?

Talkspace's Board of Directors approved an additional $25 million share repurchase program on August 1, 2024.

Talkspace, Inc.

NASDAQ:TALK

TALK Rankings

TALK Latest News

TALK Stock Data

507.61M
163.28M
3.13%
59.95%
2.6%
Health Information Services
Services-health Services
Link
United States of America
NEW YORK